高糖通过HSD17B10 K105乳酸化诱导脂滴积聚损害认知功能

High glucose impairs cognitive function by inducing lipid droplet accumulation through lactylation of HSD17B10 at K105

📅 2026-06-11 | 📰 Cell Reports | IF 9.9

Claude 评分

逻辑完整性

★★★★

方法学水平

★★★★

创新性

★★★☆

可借鉴性

★★★★

临床转化

★★★☆

总分：38 / 50 ⭐

📋 文章速览

该研究通过乳酸化组学分析(lactylome analysis)，发现高糖通过上调乳酸转移酶Aars1，介导海马神经元中HSD17B10 K105位点乳酸化修饰，导致HSD17B10酶活性降低、脂滴异常积聚、神经元凋亡和认知功能障碍。值得注意的是，靶向HSD17B10 K105乳酸化的竞争性短肽能够显著改善糖尿病小鼠的认知缺陷。大规模前瞻性队列研究进一步证实血浆HSD17B10 K105乳酸化水平可作为认知功能障碍的独立预测因子。

💡 核心发现：乳酸转移酶Aars1介导的HSD17B10 K105乳酸化 → 脂滴代谢紊乱 → 神经元凋亡 → 认识障碍。竞争性短肽阻断策略可行。

📊 图文深度解读

Figure 1
Fig. 1: Lactylome profiling identifies HSD17B10 K105 as a novel lactylation site under high glucose conditions. (A) Experimental workflow for lactylome analysis in hippocampal neurons. (B) Heatmap showing differentially lactylated proteins. (C) Validation of HSD17B10 K105 as a high-confidence lactylation site. (D) Immunoblot confirmation with site-specific anti-HSD17B10 K105lac antibody.

🔬 复现建议：可在您的课题中开展类似的全蛋白组乳酸化组学筛选，结合高糖/高乳酸处理体系，鉴定PCAF介导的新底物。

Figure 2
Fig. 2: High glucose upregulates lactyltransferase Aars1, which mediates HSD17B10 K105 lactylation. (A) Screening of candidate lactyltransferases reveals Aars1 as the writer for HSD17B10 K105 lactylation. (B) Co-IP validation of Aars1-HSD17B10 interaction. (C) In vitro lactylation assay confirming Aars1-mediated HSD17B10 modification. (D) Aars1 knockdown abrogates HSD17B10 K105 lactylation.

🔬 复现建议：借鉴Aars1 writer鉴定流程（Co-IP + 体外乳酸化反应 + 位点突变排除），验证PCAF是否为RhoA K118/K162的直接writer。

Figure 3
Fig. 3: HSD17B10 K105 lactylation reduces enzyme activity, leading to lipid droplet accumulation in hippocampal neurons. (A) HSD17B10 enzyme activity assay under high glucose ± Aars1 modulation. (B) K105R (lactylation-deficient) mutant restores HSD17B10 activity. (C) BODIPY staining showing lipid droplet accumulation in high glucose-treated neurons. (D) Quantification of lipid droplet accumulation. (E) K105R mutation rescues lipid droplet accumulation.

🔬 复现建议：K→R（乳酸化缺失）/ K→Q（模拟乳酸化）突变体功能验证策略可直接迁移到RhoA K118/K162位点研究。

Figure 4
Fig. 4: Lipid droplet accumulation drives neuronal apoptosis and cognitive decline. (A) TUNEL staining showing increased neuronal apoptosis under high glucose. (B) K105R mutant rescues neuronal survival. (C) Morris water maze behavioral test in diabetic mice. (D) Y-maze test results. (E) Correlation between HSD17B10 K105 lactylation levels and cognitive performance.

🔬 复现建议：体内功能验证范式（行为学 + 组织学 + 生化检测）可迁移，但需将检测指标替换为mitoxyperiosis相关标志物。

Figure 5
Fig. 5: A competitive peptide targeting HSD17B10 K105 lactylation rescues cognitive impairment. (A) Peptide design strategy: a short peptide spanning the K105 region of HSD17B10. (B) Peptide efficacy in blocking HSD17B10 K105 lactylation in vitro. (C) In vivo administration of the competitive peptide reduces lactylation levels in hippocampus. (D) Peptide treatment rescues lipid droplet accumulation. (E) Morris water maze improvement after peptide treatment.

🔬 复现建议：竞争性抑制短肽策略可直接复用！可设计覆盖RhoA K118/K162区域的短肽，阻断PCAF介导的乳酸化，观察mitoxyperiosis是否重启。

Figure 6
Fig. 6: Plasma HSD17B10 K105 lactylation as a predictive biomarker for cognitive decline. (A) Large-scale prospective cohort study design. (B) Plasma HSD17B10 K105 lactylation levels correlate with cognitive scores. (C) Receiver operating characteristic (ROC) curve analysis. (D) Multivariate regression identifying HSD17B10 K105 lactylation as an independent predictor.

🔬 复现建议：生物标志物思路可借鉴——血浆中RhoA乳酸化水平是否可作为肿瘤代谢重编程的指标？

Figure 7
Fig. 7: Working model. High glucose → increased lactate → Aars1 upregulation → HSD17B10 K105 lactylation → reduced enzyme activity → lipid droplet accumulation → neuronal apoptosis → cognitive impairment. Competitive peptide blocking K105 lactylation rescues the phenotype.

🔬 复现建议：完整机理模型图的构建逻辑——代谢变化 → PTM修饰 → 蛋白功能改变 → 细胞表型 → 疾病结局——值得学习。

📝 评述与借鉴

✅ 优势：

① 完整的代谢-PTM-疾病因果链（高糖→乳酸→Aars1→乳酸化→酶活↓→脂滴→凋亡→认知↓）

② 验证范式成熟：K→R位点缺失突变 + K→Q模拟突变 + 功能回复实验

③ 竞争性抑制短肽策略具转化潜力

④ 大规模人群队列验证增加临床相关性

⚠️ 缺憾：

① Cell Reports级别，部分机制深度有限（Aars1调控上游不明确）

② 乳酸化修饰研究框架较常规，创新天花板不高

③ 竞争性短肽的药理学特性（半衰期、BBB穿透）未充分讨论

🔬 对您课题的直接可借鉴性：

1. 乳酸化位点验证范式：K→R/K→Q突变体策略可直接迁移到RhoA K118/K162

2. Writer鉴定流程：Co-IP + 体外乳酸化反应 + 突变排除 → 验证PCAF-RhoA

3. 竞争性短肽策略：设计RhoA K118/K162区域短肽阻断PCAF介导的乳酸化 → 高创新性实验

4. 代谢→PTM→疾病的因果链构建逻辑：完整的研究范式参考

📌 文章小结

本研究揭示了高糖通过乳酸化修饰调控脂滴代谢的新机制：高糖→乳酸积累→Aars1上调和HSD17B10 K105乳酸化→酶活性降低→脂滴积聚→神经元凋亡→认知障碍。

对你的课题价值：这篇论文提供了完整的代谢→乳酸化→细胞命运的因果链构建范式，以及K→R/K→Q突变体验证策略、竞争性短肽阻断策略——这些都是你研究Warburg乳酸→PCAF→RhoA乳酸化→mitoxyperiosis轴时可以直接借用或借鉴的方法论。

论文信息

DOI: 10.1016/j.celrep.2026.117550

期刊: Cell Reports (IF 9.9) | 发表日期: 2026-06-11

关键词: lactylation, HSD17B10, lipid droplet, cognitive impairment, Aars1